BR112012016744A2 - "método e kits para detectar fatores de risco para o desenvolvimento de osteonecrose da mandíbula e métodos de tratamento da mesma" - Google Patents
"método e kits para detectar fatores de risco para o desenvolvimento de osteonecrose da mandíbula e métodos de tratamento da mesma"Info
- Publication number
- BR112012016744A2 BR112012016744A2 BR112012016744A BR112012016744A BR112012016744A2 BR 112012016744 A2 BR112012016744 A2 BR 112012016744A2 BR 112012016744 A BR112012016744 A BR 112012016744A BR 112012016744 A BR112012016744 A BR 112012016744A BR 112012016744 A2 BR112012016744 A2 BR 112012016744A2
- Authority
- BR
- Brazil
- Prior art keywords
- kits
- treating
- development
- methods
- risk factors
- Prior art date
Links
- 208000029985 osteonecrosis of the jaw Diseases 0.000 title 1
- FVYMVLTWIBGEMC-UHFFFAOYSA-M sodium;2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetate Chemical compound [Na+].[O-]C(=O)CSC1=NN=C(Br)N1C(C1=CC=CC=C11)=CC=C1C1CC1 FVYMVLTWIBGEMC-UHFFFAOYSA-M 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29273010P | 2010-01-06 | 2010-01-06 | |
| PCT/US2010/060139 WO2011084387A2 (en) | 2010-01-06 | 2010-12-13 | Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012016744A2 true BR112012016744A2 (pt) | 2017-06-13 |
Family
ID=44306025
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012016744A BR112012016744A2 (pt) | 2010-01-06 | 2010-12-13 | "método e kits para detectar fatores de risco para o desenvolvimento de osteonecrose da mandíbula e métodos de tratamento da mesma" |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20130035314A1 (enExample) |
| EP (1) | EP2521793A4 (enExample) |
| CN (1) | CN102812132A (enExample) |
| AU (1) | AU2010340161A1 (enExample) |
| BR (1) | BR112012016744A2 (enExample) |
| CA (1) | CA2786545A1 (enExample) |
| IN (1) | IN2012DN06571A (enExample) |
| RU (1) | RU2012133434A (enExample) |
| WO (1) | WO2011084387A2 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2724896A1 (en) * | 2008-07-07 | 2010-01-14 | University Of Florida Research Foundation, Inc. | Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof |
| US20160298192A1 (en) * | 2013-12-04 | 2016-10-13 | Micromedic Technologies Ltd. | Methods and kits for identifying susceptibility to antiresorptive-agent-induced osteonecrosis of the jaw |
| CN111518882B (zh) * | 2019-02-03 | 2022-06-28 | 陈卫衡 | 通过分子标志物辨识激素性股骨头坏死的中医证型的系统 |
| CN112410413A (zh) * | 2020-09-24 | 2021-02-26 | 吉林大学 | Onfh易感相关vdr、mmp2、mmp3、mmp9基因snp的检测物质及应用 |
| ES2994026A1 (es) * | 2023-07-11 | 2025-01-16 | Fundacion Instituto De Investig Sanitaria De Santiago De Compostela | Metodo in vitro para identificar si un sujeto tratado con agentes modificadores de los huesos puede desarrollar osteonecrosis de los maxilares |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003062465A1 (es) * | 2002-01-25 | 2003-07-31 | Universidad De Barcelona | Compuestos para el diagnóstico de la predisposición a la osteoporosis |
| CA2724896A1 (en) * | 2008-07-07 | 2010-01-14 | University Of Florida Research Foundation, Inc. | Methods and kits for detecting risk factors for development of jaw osteonecrosis and methods of treatment thereof |
-
2010
- 2010-12-13 WO PCT/US2010/060139 patent/WO2011084387A2/en not_active Ceased
- 2010-12-13 RU RU2012133434/15A patent/RU2012133434A/ru not_active Application Discontinuation
- 2010-12-13 AU AU2010340161A patent/AU2010340161A1/en not_active Abandoned
- 2010-12-13 US US13/520,785 patent/US20130035314A1/en not_active Abandoned
- 2010-12-13 CN CN2010800648762A patent/CN102812132A/zh active Pending
- 2010-12-13 IN IN6571DEN2012 patent/IN2012DN06571A/en unknown
- 2010-12-13 BR BR112012016744A patent/BR112012016744A2/pt not_active IP Right Cessation
- 2010-12-13 CA CA2786545A patent/CA2786545A1/en not_active Abandoned
- 2010-12-13 EP EP10842489.6A patent/EP2521793A4/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011084387A3 (en) | 2011-10-27 |
| EP2521793A2 (en) | 2012-11-14 |
| IN2012DN06571A (enExample) | 2015-10-23 |
| US20130035314A1 (en) | 2013-02-07 |
| RU2012133434A (ru) | 2014-02-27 |
| WO2011084387A2 (en) | 2011-07-14 |
| CN102812132A (zh) | 2012-12-05 |
| CA2786545A1 (en) | 2011-07-14 |
| EP2521793A4 (en) | 2013-07-03 |
| AU2010340161A1 (en) | 2012-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201270676A1 (ru) | Полиморфная, кристаллическая и мезофазная формы 2-(5-бром-4-(4-циклопропилнафталинил-1-ил)-4н-1,2,4-триазол-3- илтио)ацетата натрия и их применение | |
| BR112013016982A2 (pt) | formas polimórficas de ácido 2-(5-bromo-4-(4-ciclopropilnaftalen-1-il)-4h-1,2,4-triazol-3-iltio)acético e usos destes | |
| CL2019003049A1 (es) | Compuestos de heteroarilo bicíclicos 6-6 fusionados y su uso como inhibidores de lats. | |
| EA201390772A1 (ru) | Новые соли и полиморфные формы афатиниба | |
| CY1120318T1 (el) | Υποκατεστημενες βενζυλινδαζολες για χρηση ως αναστολεις κινασης bub1 στη θεραπευτικη αντιμετωπιση υπερπολλαπλασιαστικων ασθενειων | |
| CL2017001426A1 (es) | Nuevos compuestos de 5-amino-6h-tiazolo[4,5-d]pirimidin-2,7-diona 3-sustituidos para el tratamiento y profilaxis de infecciones virales. | |
| BR112016015236A8 (pt) | composto,composição farmacêutica,uso de um composto,método de inibição e método para tratar ou aliviar a gravidade de uma doença. | |
| CY1120031T1 (el) | Αποπτωτικοι υποκινητες ν-ακυλοσουλφοναμιδης | |
| TN2016000529A1 (en) | Substituted dihydroisoquinolinone compounds | |
| BR112017012342A2 (pt) | compostos inibitórios de bcl-xl e conjugados de anticorpo-fármaco incluindo os mesmos | |
| MX2020002924A (es) | Lactamas fusionadas de arilo y heteroarilo. | |
| EA201200174A1 (ru) | Производные оксазина и их применение в качестве ингибиторов bace для лечения неврологических нарушений | |
| BR112015001608A2 (pt) | inibidor lfa-1 e polimorfo do mesmo | |
| BR112014018990A8 (pt) | Derivados de ácido benzotiazol-6-il acético e seu uso para tratamento de uma infecção | |
| BR112014021531A2 (pt) | composto, composição farmacêutica e usos dos mesmos | |
| DK2321295T3 (da) | 4-(pyridin-4-yl)-1h-[1,3,5]triazin-2-olderivater som gsk3-beta inhibitorer for til behandling af neurodegenerative sygdomme | |
| EA201001196A1 (ru) | Соединения 4-пиридинона и их применение для лечения рака | |
| IT1391866B1 (it) | Composizione iniettabile di polinucleotidi per il trattamento di patologie osteoarticolari. | |
| PH12014501991A1 (en) | Phenicol antibacterials | |
| TW201613864A (en) | Novel compounds | |
| BR112017026535A2 (pt) | composto de fórmula estrutural i, enantiômero isolado, composição farmacêutica, método para inibir atividade do transportador de monocarboxilato mct4, método para inibir seletivamente atividade do transportador de monocarboxilato mct4, método para tratar um distúrbio mediado por transportador de monocarboxilato mct4 e uso de um composto | |
| CY1120133T1 (el) | Πυριδαζινονες ως αναστολεις ενζυμου daao | |
| CL2013002971A1 (es) | Compuestos derivados de 5-(fenil/piridinil-etinil)-2-piridina/2-pirimidina-carboxamida, moduladores mglur5; composición farmacéutica que los comprende; proceso de preparación de ellos; y su uso en el tratamiento de esquizofrenia o enfermedades cognitivas. | |
| CY1121060T1 (el) | Παραγωγα [1,2,4] τριαζολο[1,5-α] πυριμιδινης ως αναστολεις πρωτεασωματος πρωτοζωων για τη θεραπεια παρασιτικων νοσηματων οπως η λεϊσμανιαση | |
| WO2012107890A3 (en) | Crystal forms of lurasidone chlorhydrate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |